IDiyas

For the Inventor, By the Inventor

Redwood City, CA, United States of America

John C Martin

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 169(Granted Patents)


Location History:

  • Fayetteville, NY (US) (1986 - 1987)
  • Redwood City, CA (US) (1982 - 1993)

Company Filing History:

goldMedal12 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
silverMedal1 out of 47 
 
Syntex LLC
 patents

Years Active: 1982-1993

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5250535 - Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) (1993-10-05),
2. 4803271 - Process for preparing guanine derivatives (1989-02-07),
3. 4704392 - Tricyclic derivatives of substituted pyrimidines (1987-11-03),
4. 4621140 - Process for preparing (1986-11-04),
5. 4612314 - Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) (1986-09-16),
6. 4609661 - Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted (1986-09-02),
7. 4605659 - Purinyl or pyrimidinyl substituted hydroxycyclopentane compounds useful (1986-08-12),
8. 4603219 - 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for (1986-07-29),
9. 4565868 - Process for preparing guanine derivatives (1986-01-21),
10. 4556659 - Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted (1985-12-03),
11. 4507305 - 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent (1985-03-26),
12. 4423050 - 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent (1983-12-27),
13. 4355032 - 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent (1982-10-19),

Title: The Innovative Contributions of John C. Martin

Introduction

John C. Martin is a prominent inventor based in Redwood City, California. He has made significant contributions to the field of antiviral agents, holding a total of 13 patents. His work has been instrumental in advancing medical science and improving treatment options for various viral infections.

Latest Patents

Among his latest patents, Martin has developed compounds defined by specific formulas that are useful as antiviral agents. One notable patent involves substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) compounds. These compounds are characterized by their ability to act as effective antiviral agents. Another significant patent focuses on a process for preparing guanine derivatives, which also serve as antiviral agents. These innovations highlight Martin's dedication to addressing critical health challenges.

Career Highlights

Throughout his career, John C. Martin has worked with notable companies, including Syntex Inc. and Syntex LLC. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Martin has collaborated with esteemed colleagues such as Julien P. Verheyden and Daniel P. McGee. These partnerships have fostered an environment of innovation and have led to the successful development of various antiviral compounds.

Conclusion

John C. Martin's contributions to the field of antiviral agents through his patents and collaborations have made a lasting impact on medical science. His work continues to inspire future innovations in the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…